YamasakiRMatsushitaTFukazawaTet al. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Mult Scler2016; 22(10): 1337–1348.
2.
TrebstCJariusSBertheleAet al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol2013; 261(1): 1–16.
3.
La MantiaLEoliMMilaneseCet al. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol1994; 34(4): 199–203.
4.
MehrotraASaxenaRJafferyNet al. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol2007; 55(5): 355–359.
5.
SadraVKhabbaziAKolahiSet al. Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: A preliminary study. Int J Rheum Dis2014; 17(4): 389–393.
6.
Klein-GitelmanMPachmanL.Intravenous corticosteroids: Adverse reactions are more variable than expected in children. J Rheumatol2018; 25(10): 1995–2002.
